Emory University

Michael W Hager

Dennis C Liotta

Shuli Mao

Raymond F Schinazi

Provided are cyclobutyl nucleosides and methods for their use in treatment of infections including Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans.

2' and 3&#x2032;-substituted cyclobutyl nucleoside analogs for the treatment viral infections and abnormal cellular proliferation

2' and 3&#x2032;-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation

A process for the preparation of 3'-substituted-2',3'-dideoxynucleosides is provided that utilizes inexpensive, non-carbohydrate, acyclic, achiral starting materials and that proceeds with high enantiomeric and stereochemical control. The method can be used to prepare the pharmaceutically important compounds 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-fluoro-3'-deoxythymidine, and 3'-fluoro-3'-deoxyuridine.

Preparation of 3'-substituted-2',3'-dideoxynucleosides and

A process for the preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides is provided that utilizes inexpensive, non-carbohydrate, acyclic, achiral starting materials and that proceeds with high enantiomeric and stereochemical control. The method can be used to prepare the pharmaceutically important compounds 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine and 3'-fluoro-3'-deoxythymidine.

Growing community of inventors

Atlanta, GA, United States of America

Michael W Hager